IP Library › Granted Patent US 10,874,843
Granted Patent B2
US 10,874,843 · App. 15/972,611 · Granted Dec 29, 2020

Medical device hybrid polymeric structures and coatings with improved lubricity and durability

Inventors: Adegbola O. Adenusi (Burnsville, MN); James P. Rohl (Prescott, WI); David R. Wulfman (Minneapolis, MN); Joseph T. Delaney, Jr. (Minneapolis, MN); Adeniyi Aremu (Brooklyn Park, MN)
Assignee: Cardiac Pacemakers, Inc.
A61M39/08A61L29/041A61L29/06A61L29/085A61L29/145A61L29/146A61L31/048A61L31/06A61L31/10A61L31/145A61L31/146A61M39/00A61N1/056A61N1/0541B32B1/08B32B5/02B32B5/022B32B27/08B32B27/12D01D5/0023D01D5/0076D01D5/0084D01D5/0985B32B2262/0238B32B2535/00Y10T428/1372
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,874,843
App. No.
15/972,611
Granted
Dec 29, 2020
Kind
B2
Abstract

A medical device made of a hybrid polymeric structure includes a tubular body including a first layer and a second layer. The first layer includes a fibrous matrix comprising a plurality of randomly oriented nanofibers made at least in part of a first polymeric material and pores formed between at least a portion of the nanofibers. The second layer is made at least in part of a second polymeric material. At least a portion of the second layer is disposed about and between the plurality of nanofibers such that at least a portion of the second polymeric material is embedded into at least a portion of the pores of the fibrous matrix.

Claims (31)

1. A medical device made of a hybrid polymeric structure comprising:

a tubular body including a first layer and a second layer;

the first layer including a fibrous matrix comprising a plurality of randomly oriented nanofibers made at least in part of a first polymeric material and pores formed between at least a portion of the nanofibers; and

the second layer made at least in part of a second polymeric material;

wherein at least a portion of the second layer made of the second polymeric material is disposed about and between the plurality of nanofibers such that at least a portion of the second polymeric material is embedded into at least a portion of the pores of the fibrous matrix;

wherein the first layer further comprises a cross-linked hydrogel made at least in part of a third polymeric material disposed about and between the plurality of nanofibers.

2. The medical device of claim 1 , wherein the first layer includes the fibrous matrix made at least in part of the first polymeric material comprising poly(vinylidene fluoride-co-hexafluoropropylene) (PVDF HFP).

3. The medical device of claim 1 , wherein the fibrous matrix comprising the plurality of randomly oriented nanofibers, wherein a portion of the nanofibers are fused to one another.

4. The medical device of claim 1 , wherein the second layer is made at least in part of the second polymeric material comprising silicone.

5. The medical device of claim 1 , wherein the cross-linked hydrogel is made at least in part of the third polymeric material comprising polyethylene glycol (PEG).

6. The medical device of claim 1 , further including a third layer disposed between the first layer and the second layer, the third layer including a portion of the fibrous matrix and not including the second polymeric material or the third polymeric material.

7. The medical device of claim 1 , wherein the first layer forms a first surface of the device and the second layer forms a second surface of the device.

8. The medical device of claim 7 , wherein the first surface is an inner surface of the tubular body and the second surface is an outer surface of the tubular body.

9. A medical device comprising:

a tubular body including an outer surface, an inner surface, and a layer extending from the first surface to the second surface, the layer including:

a fibrous matrix including a plurality of randomly oriented nanofibers made at least in part of a first polymeric material and pores formed between at least a portion of the nanofibers;

a first polymeric network disposed within at least a portion of the pores, the first polymeric network made at least in part of a second polymeric material, the second polymeric material different from the first polymeric material; and

a second polymeric network disposed within at least a portion of the pores, the second polymeric network made a least in part of a third polymeric material, the third polymeric material different from the first polymeric material and the second polymeric material.

10. The medical device of claim 9 , wherein the first polymeric material includes poly(vinylidene fluoride-co-hexafluoropropylene).

11. The medical device of claim 9 , wherein the second polymeric material includes silicone.

12. The medical device of claim 9 , wherein the first polymeric material is hydrophobic and the third polymeric material is hydrophilic.

13. A medical device comprising:

a tubular body including an outer surface, an inner surface, and a layer extending from the outer surface to the inner surface, the layer including:

a fibrous matrix including a plurality of randomly oriented nanofibers, the plurality of randomly oriented nanofibers including:

a first plurality of nanofibers made at least in part of a first polymeric material, wherein the first polymeric material includes poly(styrene-isobutylene-styrene), polyisobutylene polyurethane, or a combination thereof; and

a second plurality of nanofibers made a least in part of a second polymeric material, wherein the second polymeric material includes polyethylene glycol.

14. The medical device of claim 13 , wherein the first plurality of nanofibers consists of the first polymeric material; and the second plurality of nanofibers consists of the second polymeric material.

15. The medical device of claim 13 , wherein the first polymeric material is hydrophobic and the second polymeric material is hydrophilic.

16. The medical device of claim 13 , wherein the first polymeric material is a thermoset material and the second polymeric material is a thermoplastic material, or the second polymeric material is a thermoset material and the first polymeric material is a thermoplastic material.

17. The medical device of claim 13 , wherein the first polymeric material is an electrically conductive material and the second polymeric material is an electrically non-conductive material, or the second polymeric material is an electrically conductive material and the first polymeric material is an electrically non-conductive material.

18. The medical device of claim 13 , wherein the first polymeric material includes poly(vinylidene fluoride-co-hexafluoropropylene).

Continuity (3)
Division 14600611 · Jan 20, 2015
Provisional Application 61929886 · Jan 21, 2014
Related Publication 20180264248A1 · Sep 20, 2018
Cited By (1)
US 12,245,935